MedAdvisor Limited

MedAdvisor Limited

MDR.AX
MedAdvisor LimitedAU flagAustralian Securities Exchange
0.02
AUD
- -
- -
14.00MMarket Cap
MedAdvisor Limited
MDR.AX
(Australian Securities Exchange)

Recent

price

0.02

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
FRC
- -
- -
- -
- -
- -
- -
0.02
0.03
0.04
0.04
0.04
0.12
0.18
0.18
0.22
Revenue per Share
- -
-0.07
-0.27
-0.47
-1.05
-0.06
-0.05
-0.03
-0.03
-0.04
-0.04
-0.04
-0.05
-0.02
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
-0.02
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.18
2.92
0.75
1.2
-0.03
-0.02
0.03
0.06
0.08
0.04
0.06
0.15
0.08
0.08
0.08
Book Value per Share
0.18
2.94
0.75
1.4
0.03
-0.01
0.04
0.03
0.06
0.02
0.05
-0.02
-0.06
-0.03
-0.02
Tangible Book Value per Share
18
1
4
8
11
12
63
125
177
194
235
317
378
545
548
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
1
4
7
8
10
39
68
98
122
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
-224.21
-94.66
-79.21
-109.64
-115.93
-47.23
-23.89
-8.61
2.21
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
3
5
5
4
Depreciation Expense
- -
- -
-1
-4
-11
-1
-3
-3
-4
-8
-10
-14
-17
-11
1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
14.23
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
-215.4
-80.84
-67.44
-98.29
-99.82
-35.98
-25.6
-11.54
0.65
Profit Margin (%)
3
3
2
2
- -
- -
2
4
10
3
12
-2
-24
-5
-13
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
8
8
12
- -
LT Debt
3
3
3
11
- -
- -
2
9
15
9
17
49
35
48
52
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3.65
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4.34
Return on Capital (%)
- -
-2.24
-33.83
-60.9
- -
- -
- -
-68.99
-41.37
-77.43
-84.9
-45.11
-45.06
-31.08
1.82
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-194.01%
60.26%
6.44%
Free Cash Flow
- -
219.25%
926.41%
Net Income, GAAP
33.62%
-10.73%
-107.01%
Sales/Revenue/Turnover
- -
92.85%
24.64%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
68
2023
- -
- -
- -
- -
98
2024
- -
- -
- -
- -
122

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
-0.05
2023
- -
- -
- -
- -
-0.02
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Business
MedAdvisor Limited MedAdvisor Limited (MDR.AX) provides pharmacy-driven patient engagement solutions that simplify the medication journey through personalized digital experiences for patients, pharmacists, and pharmaceutical companies. The company offers core products including THRiV, an AI-enabled omni-channel platform for patient and pharmacist engagement, medication adherence, and workflow optimization; MedAdvisor, a mobile app and cloud-based software for prescription management, eScript uploads, automated reminders, clinical workflow recording, and vaccination services; and GuildCare, a platform delivering healthcare solutions and medicines information to consumers and professionals. These solutions support omnichannel communications, hyper-personalized programs for brand awareness, adherence, refills, and vaccine initiatives, leveraging predictive analytics and a 360-degree patient view. MedAdvisor Limited operates in the healthcare technology sector, targeting community pharmacies, pharmaceutical companies, and patients, with key markets in Australia and New Zealand, where it connects with over 95% of pharmacies and 3.7 million patients; the United States, reaching over 34,000 pharmacies and two-thirds of the population; and the United Kingdom and Asia. Founded in 2010 and headquartered in Camberwell, Victoria, Australia, the company maintains a network spanning over 37,000 pharmacies globally and emphasizes AI-powered personalization and data-driven outcomes. Recent developments include a strategic partnership with Mindsprint announced in December 2024 to co-innovate advanced medication management platforms integrating AI for enhanced patient support and healthcare efficiencies; the appointment of John Ciccio as new CEO and Managing Director; expansion of clinical services enabling Australian pharmacists to deliver over 115,000 interventions for conditions like UTIs, asthma, and immunizations; and a non-binding letter of intent in May 2025 for Jonas Software AUS Pty Ltd to acquire MedAdvisor International Pty Ltd for AUD 42.35 million.